semaglutide chinese biotech aims to finish trials by 2028 for spray with Wegovy active ingredient Novo Nordisk and Eli Lilly

MOTS-c vs NAD+: How Two Mitochondrial Compounds Compare and When a Clinic Uses Both MOTS-c and NAD+ both target mitochondrial function, but through different pathways

Scientific Data: In the SURPASS trials, tirzepatide showed higher rates of gastrointestinal side effects compared to semaglutide, but these were generally temporary and resolved as treatment continued

Truveta is focused on making this kind of research possible, helping translate everyday clinical data into insights that reflect how treatments actually work across diverse populations

Eli Lillys orforglipron (Foundayo) was the oral GLP-1 used in recent research showing that it can help to maintain weight loss after using an injectable